Close Menu

NEW YORK (GenomeWeb) – Aegis Sciences has acquired molecular diagnostics firm Diagnovus for an undisclosed amount, the companies said today.

Diagnovus, based in Nashville, Tenn., has developed a suite of oncology and gastroenterology tests using a range of technologies, including PCR, next-generation sequencing, and gene expression analysis. In addition, it offers clinical trial, bioinformatics, and other clinical services on a variety of technology platforms.

Aegis, also based in Nashville, is a toxicology laboratory that specializes in forensic and healthcare services.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.